PMINYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Picard Medical, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$15.45+2.70 (+21.18%)
Close on Oct 19, 2026
- Market cap
- $28.67M
- P/E (TTM)
- –
- Dividend yield
- –
Picard Medical, Inc. revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Product [Member] | $2.94M | $943.00K | $887.00K | $1.12M | $2.13M | $613.00K | $756.00K | $881.00K | – | 99.4% | +37.7% |
| Rentals [Member] | $19.00K | $207.00K | $122.00K | $72.00K | $0 | $7.00K | $80.00K | $0 | – | 0.6% | – |
| Products [Member] | – | – | – | – | $2.13M | – | – | – | $694.00K | – | – |
By region
From the segment and revenue-disaggregation notes of Picard Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.